BioSpace News Archive

Collaboration agreement between Thermo Fisher Scientific and Artificial enables improved integration of software and robotics platforms to maximize COVID-19 testing throughput and efficiency

Fresenius Medical Care North America and DaVita Kidney Care announced an expanded agreement to provide home dialysis technology—including NxStage home hemodialysis machines, dialysis supplies, and a connected health platform—to DaVita patients across the United States.

DNA Script, a leader in revolutionizing DNA synthesis on demand to accelerate scientific breakthroughs, has appointed Philippe Lyko as its new Chief Financial Officer.

Emalex Biosciences, Inc. (“Emalex”), a biopharmaceutical company founded to develop treatments for central nervous system movement disorders and fluency disorders, today announced $35 million in Series C Preferred Stock funding led by Paragon Biosciences. Fidelity Management & Research Company LLC and Valor Equity Partners joined the round.

Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced it received authorization from the U.S. Food and Drug Administration to update key claims for the VITROS® SARS-CoV-2 Antigen Test, the first high-volume SARS-CoV-2 antigen assay to receive Emergency Use Authorization (EUA) in the United States.

- Renovacor, Inc. has entered into a definitive merger agreement with Chardan Healthcare Acquisition 2 Corp. (NYSE: CHAQ) - - Upon closing, the combined company is expected to receive up to $116 million in proceeds and is expected to be listed on NYSE under the ticker symbol “RCOR” -

March 22 through March 28, 2021 is National Drug and Alcohol Facts Week®, an annual, week-long, health observance developed by the National Institute on Drug Abuse to raise awareness about substance abuse, including alcohol, and addiction in communities across the U.S.

A new study published in the Journal of General Internal Medicine showed that while preventative cancer screenings for breast and colorectal cancers declined significantly during the early days of the COVID-19 pandemic, use of these procedures returned to near-baseline levels by the end of July 2020.

Arcadia Biosciences, Inc. ® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional content of crops, today announced that it will release its 2020 fourth-quarter and full-year financial and business results after market close on March 30, 2021 .

Maitri Health Technologies Corp. (“Maitri”) (CSE: MTEC) (FRA: D84), a global platform for healthcare supply security, today announced the appointment of Bridget Ross to its Advisory Board.